文献速递淋巴瘤

具有T滤泡辅助表型的外周T细胞淋巴瘤:一种不同的实体?西班牙Real-T研究结果

Peripheral T-cell lymphoma with a T follicular-helper phenotype: A different entity? Results of the Spanish Real-T study.
PubMed 文献 · Br J Haematol · 2023-06-30

该回顾性观察研究纳入2008至2013年西班牙13个中心的175例外周T细胞淋巴瘤患者,中心病理复阅后按WHO 2016标准重新分类为PTCL-NOS 21例、AITL 55例、PTCL-TFH 23例。中位随访56.07个月(95% CI 38.7-73.4),PTCL-TFH的无进展生存和总生存均显著优于PTCL-NOS和AITL。

要点

  • PTCL-TFH中位PFS 24.6个月,PTCL-NOS 4.6个月、AITL 7.8个月(p=0.002)。
  • PTCL-TFH中位OS 52.6个月,PTCL-NOS 10.0个月、AITL 19.3个月(p<0.001)。
  • 组织学诊断对PFS和OS保持独立影响,且不受国际预后指数影响。

核心结论

  • 结果提示PTCL-TFH可能较其他PTCL亚型具有更有利的特征和预后,但需要更大样本系列来证实这些发现。

研究设计与样本

  • 回顾性观察研究,纳入2008至2013年西班牙13个中心诊断的175例PTCL患者,诊断经中心复阅并按WHO 2016标准重新分类。

主要发现

  • 中位随访56.07个月(95% CI 38.7-73.4)。
  • PTCL-TFH中位PFS 24.6个月 vs PTCL-NOS 4.6个月、AITL 7.8个月(p=0.002)。
  • PTCL-TFH中位OS 52.6个月 vs PTCL-NOS 10.0个月、AITL 19.3个月(p<0.001)。
  • 组织学诊断对PFS保持独立影响:vs PTCL-NOS HR 4.1(p=0.008),vs AITL HR 2.6(p=0.047)。
  • 组织学诊断对OS保持独立影响:vs PTCL-NOS HR 5.7(p=0.004),vs AITL HR 2.6(p=0.096)。

关键数值与推荐

  • 按WHO 2016标准重新分类:PTCL-NOS 21例、AITL 55例、PTCL-TFH 23例。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文指出需要更大样本系列来证实这些发现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Nodal peripheral T-cell lymphoma (PTCL) with a T follicular helper phenotype (PTCL-TFH) is a new type of PTCL. We aimed to define its clinical characteristics and prognosis compared to PTCL not otherwise specified (PTCL-NOS) and angioimmunoblastic T-cell lymphoma (AITL). This retrospective observational study included 175 patients diagnosed with PTCL between 2008 and 2013 in 13 Spanish sites. Patient diagnosis was centrally reviewed, and patients were reclassified according to the World Health Organization (WHO) 2016 criteria: 21 patients as PTCL-NOS, 55 as AITL and 23 as PTCL-TFH. Median follow-up was 56.07 months (95% CI 38.7-73.4). Progression-free survival (PFS) and overall survival (OS) were significantly higher in patients with PTCL-TFH than in those with PTCL-NOS and AITL (PFS, 24.6 months vs. 4.6 and 7.8 months, respectively, p = 0.002; OS, 52.6 months vs. 10.0 and 19.3 months, respectively, p < 0.001). Histological diagnosis maintained an independent influence on both PFS (hazard ratio [HR] 4.1 vs. PTCL-NOS, p = 0.008; HR 2.6 vs. AITL, p = 0.047) and OS (HR 5.7 vs. PTCL-NOS, p = 0.004; HR 2.6 vs. AITL, p = 0.096), regardless of the International Prognostic Index. These results suggest that PTCL-TFH could have more favourable features and prognosis than the other PTCL subtypes, although larger series are needed to corroborate these findings.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Martín García-Sancho A, Rodríguez-Pinilla SM, Domingo-Domenech E, et al. Peripheral T-cell lymphoma with a T follicular-helper phenotype: A different entity? Results of the Spanish Real-T study. Br J Haematol. 2023. PMID: 37386897. doi:10.1111/bjh.18941

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。